Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Hui Zhou   and   Matthew Mefford.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.722
         
        
        
     
 
    
        
        - 
            Health Literacy and Treatment Satisfaction Among Patients with Venous Thromboembolism. J Gen Intern Med. 2022 Nov 03.
            
            
                Score: 0.206
            
         
        
        - 
            Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions. JAMA Netw Open. 2022 04 01; 5(4):e228031.
            
            
                Score: 0.198
            
         
        
        - 
            Sociopolitical stress and acute cardiovascular disease hospitalizations around the 2016 presidential election. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):27054-27058.
            
            
                Score: 0.179
            
         
        
        - 
            Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19. Int J Cardiol Cardiovasc Risk Prev. 2021 Dec; 11:200117.
            
            
                Score: 0.048
            
         
        
        - 
            COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system. Int J Cardiol Hypertens. 2021 Jun; 9:100088.
            
            
                Score: 0.047
            
         
        
        - 
            Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
            
            
                Score: 0.045